Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merce Jorda

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
European Urology|October 23, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: PathologyMahul B Amin, Jesse K McKenney, Gladell P Paner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2020
Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation TherapyAlan Pollack, Felix M Chinea, Elizabeth Bossart, et al.
Nature Communications|November 2, 2017
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancerGovindi J Samaranayake, Clara I Troccoli, Mai Huynh, et al.
Archives of Pathology & Laboratory Medicine|October 20, 2021
Anterior or Posterior Prostate Cancer Tumor Nodule Location Predicts Likelihood of Certain Adverse Outcomes at Radical ProstatectomyAmin Hayee, Isabella Lugo, Oleksii A Iakymenko, et al.
Cancer Cytopathology|April 9, 2024
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performanceOdille Mejia-Mejia, Andres Bravo-Gonzalez, Monica Sanchez-Avila, et al.
Human Pathology|May 4, 2018
Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation teamAram Vosoughi, Paul Taylor Smith, Joseph A Zeitouni, et al.
Oncogene|September 5, 2018
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasisMichael D Birnbaum, Ning Zhao, Balaji T Moorthy, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistanceLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.
American Journal of Clinical Pathology|February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancersOleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.
Archives of Pathology & Laboratory Medicine|November 5, 2021
Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical ProstatectomyOleksandr N Kryvenko, Oleksii A Iakymenko, Luiz P De Lima Guido, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
European Urology|October 23, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: PathologyMahul B Amin, Jesse K McKenney, Gladell P Paner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2020
Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation TherapyAlan Pollack, Felix M Chinea, Elizabeth Bossart, et al.
Nature Communications|November 2, 2017
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancerGovindi J Samaranayake, Clara I Troccoli, Mai Huynh, et al.
Archives of Pathology & Laboratory Medicine|October 20, 2021
Anterior or Posterior Prostate Cancer Tumor Nodule Location Predicts Likelihood of Certain Adverse Outcomes at Radical ProstatectomyAmin Hayee, Isabella Lugo, Oleksii A Iakymenko, et al.
Cancer Cytopathology|April 9, 2024
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performanceOdille Mejia-Mejia, Andres Bravo-Gonzalez, Monica Sanchez-Avila, et al.
Human Pathology|May 4, 2018
Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation teamAram Vosoughi, Paul Taylor Smith, Joseph A Zeitouni, et al.
Oncogene|September 5, 2018
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasisMichael D Birnbaum, Ning Zhao, Balaji T Moorthy, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
The soluble guanylyl cyclase pathway is inhibited to evade androgen deprivation-induced senescence and enable progression to castration resistanceLing Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano, et al.
American Journal of Clinical Pathology|February 27, 2024
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancersOleksandr N Kryvenko, Jonathan I Epstein, Ali Merhe, et al.
Archives of Pathology & Laboratory Medicine|November 5, 2021
Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical ProstatectomyOleksandr N Kryvenko, Oleksii A Iakymenko, Luiz P De Lima Guido, et al.
Pageof 12